18:05 IST
BSE
Earnings Call
Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Management is optimistic as the new Dombivli hospital ramps up, despite it causing a 9.5 crore EBITDA drag this quarter.
Jupiter Life Line Hospitals Ltd
- Share price
- ₹265.65
- Market cap
- ₹8,709 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 46.4×Sector 57.8×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
18:07 IST
BSE
Earnings Call
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Jupiter Life Line Hospitals reported Q1FY27 revenue growth of 16.2% YoY, while PAT declined 14.7% due to higher depreciation and finance costs from the new Dombivli facility.
16:46 IST
BSE
Financial Results
Jupiter Life Line Hospitals Q1 FY27 Results: Net Profit ₹37.5 Cr, Down 14.6% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹411 Cr (+16.4% YoY) and net profit of ₹37.5 Cr (-14.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹37.5 Cr · -14.6% YoY
12:38 IST
BSE
Earnings Call
Jupiter Life Line Hospitals Earnings Call: Key Takeaways
Jupiter reports strong FY26 performance with 15.2% revenue growth to ₹1,499.8cr. Focus remains on greenfield expansion in Western India with asset-heavy ownership model.
15:20 IST
NSE
Earnings Call
Jupiter Life Line Hospitals Earnings Call: Key Takeaways
Jupiter is aggressively expanding in Western India, leveraging its asset-heavy model to build high-capacity flagship hospitals in Mumbai and Pune.